Rubrik Reports Q2 Results, Joins Ionis Pharmaceuticals, Hewlett Packard Enterprise And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Portfolio Pulse from Avi Kapoor
Rubrik, Ionis Pharmaceuticals, Hewlett Packard Enterprise, and other major stocks experienced declines in Tuesday's pre-market session. Rubrik reported better-than-expected Q2 results but still saw an 8.1% drop in share price. Ionis Pharmaceuticals and Hewlett Packard Enterprise also faced declines due to public offerings.
September 10, 2024 | 12:32 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Hewlett Packard Enterprise shares fell 5.2% in pre-market trading following the announcement of a $1.35 billion public offering of Series C mandatory convertible preferred stock.
The announcement of a large public offering likely led to concerns about dilution, causing the share price to drop.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Ionis Pharmaceuticals' shares declined 7% in pre-market trading after pricing a $500.3 million public offering at $43.50/share.
The decline in Ionis Pharmaceuticals' share price is likely due to the dilution effect of the new public offering.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Rubrik reported Q2 losses of 40 cents per share, beating estimates, and sales of $204.951 million, surpassing expectations. Despite this, shares fell 8.1% in pre-market trading.
Rubrik's better-than-expected earnings and sales were overshadowed by the overall market sentiment, leading to an 8.1% drop in pre-market trading.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100